Prognostic significance of plasma osteopontin level in breast cancer patients

Affiliations

Nassar Hanan R.: Department of Medical Oncology, National Cancer Institute, Cairo University, Egypt
Namour Alfred E.: Department of Medical Oncology, National Cancer Institute, Cairo University, Egypt
Shafik Hanan E.: Department of Medical Oncology, National Cancer Institute, Cairo University, Egypt
El Sayed Amr S.: Department of Biochemistry, Faculty of Science, Cairo University, Egypt
Kamel Samar M.: Department of Biochemistry, Faculty of Science, Helwan University, Egypt
Moneer Manar M.: Department Epidemiology and Biostatistics, National Cancer Institute, Cairo University
Zakhary Nadia I.: Department of Cancer Biology, National Cancer Institute, Cairo University

Abstract

Many studies have demonstrated that osteopontin (OPN) contributes functionally to aggressive behaviour in many tumours including breast cancer.

ISSN: 1792-362X (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://sciendo.com/journal/FCO